Exploiting the methylerythritol phosphate pathway as a source of drug targets for novel anti-infectives (MepAntI) (Joint with Helmholtz-Institute for Pharmaceutical Research (Lead), University of Groningen, French Alternative Energies and Atomic Energy Commission, Ghent University, Compound Handling BV, University of Strasbourg, University of Bergen, Research Centre Borstel, Swiss Tropical and Public Health Institute, OmicScouts GmbH)